Hiroshi Soda

19PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursTumour immunologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.

Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto

|Nov 05, 2023
TIM-3 expression induces resistance to PD-1 inhibitor in G-CSF-producing lung spindle cell carcinoma: A case report.

Fumiko Hayashi, Kazumasa Akagi, Hirokazu Taniguchi

|Sep 07, 2023
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.

Hiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda

|Mar 27, 2023
Hypertrophic osteoarthropathy associated with lung cancer: Possible links among hypoxia-inducible factor-1α, vascular endothelial growth factor, and hypervascularization.

Ryuta Tagawa, Hiroshi Soda, Yosuke Dotsu

|Aug 17, 2022
Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases.

Ryosuke Ogata, Hiroshi Soda, Hiroaki Senju

|Jul 09, 2022
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study.

Kazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda

Pageof 4

Frequent Collaborators

8 joint publications

Hirokazu Taniguchi

7 joint publications

Minoru Fukuda

5 joint publications

Shinnosuke Takemoto

4 joint publications

Hiroyuki Yamaguchi